Cargando…
Days Alive Outside Hospital and Readmissions in Patients Undergoing Allogeneic Transplants from Identical Siblings or Alternative Donors
We have studied the number of days alive outside the Hospital (DAOH) and the number of readmissions within the first 100 days after transplant in 185 patients who received an allogeneic hemopoietic stem cell transplant (HSCT). The donors were matched siblings (SIB; n=61), or alternative donors (ALT;...
Autores principales: | Sora, Federica, Chiusolo, Patrizia, Laurenti, Luca, Innocenti, Idanna, Autore, Francesco, Giammarco, Sabrina, Metafuni, Elisabetta, Alma, Eleonora, Di Giovanni, Alessia, Sica, Simona, Bacigalupo, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Università Cattolica del Sacro Cuore
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485463/ https://www.ncbi.nlm.nih.gov/pubmed/32952966 http://dx.doi.org/10.4084/MJHID.2020.055 |
Ejemplares similares
-
Is Allogeneic Transplantation an Option in Patients Affected by Concurrent Myelofibrosis and Chronic Myeloid Leukemia (CML)?
por: Sora, Federica, et al.
Publicado: (2021) -
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021
por: Bacigalupo, Andrea, et al.
Publicado: (2021) -
Hemorrhagic cystitis in allogeneic stem cell transplantation: a role for age and prostatic hyperplasia
por: Galli, Eugenio, et al.
Publicado: (2022) -
Efficacy and Tolerability of First Line Arsenic Trioxide in Combination With All-Trans Retinoic Acid in Patients With Acute Promyelocytic Leukemia: Real Life Experience
por: Autore, Francesco, et al.
Publicado: (2021) -
Predicting the outcome for patients with myelofibrosis undergoing an allogeneic hemopoietic stem cell transplant
por: Sora, Federica, et al.
Publicado: (2022)